You are here

Process development of TRI-999, a fatty-acid-modified HIV fusion inhibitory peptide

Zhang, H., Schneider, S. E., Bray, B., Friedrich, P., Tvermoes, N., Mader, C., ... Wring, S. (2007). Process development of TRI-999, a fatty-acid-modified HIV fusion inhibitory peptide. Organic Process Research and Development, 12(1), 101 - 110.

Publications Info

To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.

Recent Publications

Article

What influences evidence-based treatment sustainment after implementation support ends? A mixed method study of the adolescent-community reinforcement approach
Article

Assessing the environmental impacts of halving food loss and waste along the food supply chain
Article

Nursing home residents' perspectives on their social relationships
Article

Enhancing routine surveillance to improve stillbirth data

RTI uses cookies to offer you the best experience online. By continuing to use our website, you agree to the use of cookies. If you would like to know more about cookies and how to manage them please view our Privacy Policy. Learn More.

Got it!